Cargando…

Remdesivir for patients with COVID-19

Detalles Bibliográficos
Autores principales:	Wu, Peter E., Morris, Andrew M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Joule Inc. 2021
Materias:	Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954552/ https://www.ncbi.nlm.nih.gov/pubmed/33408097 http://dx.doi.org/10.1503/cmaj.202505

Ejemplares similares

Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man
por: Day, Leora Branfield, et al.
Publicado: (2021)

Le remdésivir chez les patients atteints de la COVID-19
por: Wu, Peter E., et al.
Publicado: (2021)

Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?
por: Prabha, Praisy K., et al.
Publicado: (2023)

Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge
por: Herz-Roiphe, R., et al.
Publicado: (2022)

Use of Remdesivir in the treatment of Coronavirus Disease 2019 (COVID-19) infection among Sudanese patients: a case series
por: Yousif, Maysoun, et al.
Publicado: (2022)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Remdesivir senkt COVID-19-Hospitalisierung
por: Dovjak, Peter, et al.
Publicado: (2022)

Treatment Experience With Inhaled Corticosteroids in Combination with Remdesivir and Dexamethasone Among COVID-19 Patients Admitted to a Rural Community Hospital: A Case Series
por: Yatam Ganesh, Santosh, et al.
Publicado: (2020)

Fluvoxamine for symptomatic outpatients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2022)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

What is the role of remdesivir in patients with COVID-19?
por: Beigel, John H.
Publicado: (2021)

Remdesivir: From Ebola to COVID-19
por: Santoro, M. Gabriella, et al.
Publicado: (2021)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
por: Whittington, Melanie D., et al.
Publicado: (2022)

Fewer COVID‐19 Neurological Complications with Dexamethasone and Remdesivir
por: Grundmann, Alexander, et al.
Publicado: (2022)

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

To Determine the Efficacy of Remdesivir in Covid-19
por: Hameed, A., et al.
Publicado: (2022)

Remdesivir: A Review in COVID-19
por: Blair, Hannah A.
Publicado: (2023)

Compassionate Use of Remdesivir for Patients with Severe Covid-19
por: Grein, Jonathan, et al.
Publicado: (2020)

Remdesivir in a pregnant patient with COVID-19 pneumonia
por: Dande, Ranadheer, et al.
Publicado: (2021)

Length of remdesivir treatment in patients with severe COVID-19
por: Ippolito, Mariachiara, et al.
Publicado: (2021)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2022)

Use of remdesivir for COVID-19 in patients with hematologic cancer
por: Martin-Onraët, Alexandra, et al.
Publicado: (2022)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2023)

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
por: Coelho, Luís, et al.
Publicado: (2023)

Remdesivir treatment for patients with moderate to severe COVID-19
por: HASANOĞLU, İmran, et al.
Publicado: (2022)

Remdesivir bei Patienten mit COVID-19
por: Augustin, M., et al.
Publicado: (2020)

Remdesivir senkt Covid-Hospitalisierungsrate
por: Dovjak, Peter, et al.
Publicado: (2022)

Tocilizumab for hospitalized patients with COVID-19
por: Afra, Kevin, et al.
Publicado: (2021)

Antithrombotic agents in patients with COVID-19
por: Khan, Faizan, et al.
Publicado: (2022)

The journey of remdesivir: from Ebola to COVID-19
por: Pardo, Joe, et al.
Publicado: (2020)

Remdesivir for the Treatment of Covid-19 — Final Report
por: Beigel, John H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4bhn7bfc0e543mv8ojspr3q752